Toggle Nav
Close
  • Menu
  • Setting

Anti-Amyloid Beta Antibody (Donanemab)

Catalog No.
F1533
Anti-Amyloid Beta Antibody (Donanemab)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody targeting the N-terminal pyroglutamate epitope of amyloid β (Aβ). Donanemab has the potential to be used in early Alzheimer's disease research.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.36 kDa

Shipping

Dry ice

Cas No.

1931944-80-7

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

LY3002813-SC, LY3002813-IV

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P05067

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

Amyloid Beta

Note

Please avoid freeze-thaw cycles.